CREATININE2
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.·Registered August 19, 2022EL ENSAYO CREATININE2 SE UTILIZA PARA LADETERMINACIÓNCUANTITATIVADECREATININAENSUERO,PLASMA U ORINA HUMANOS EN ARCHITECT C SYSTEMS.AGENTEDEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES
THE CREATININE2 ASSAY IS USED FOR THE QUANTITATIVE DETERMINATION OF CREATININE IN HUMAN SERUM, PLASMA OR URINE AT ARCHITECT C SYSTEMS. DIAGNOSTIC AGENTFOR use. FOR USE ONLY IN CLINICAL LABORATORIES OR CABINETS
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LADETERMINACIÓN CUANTITATIVA DE CREATININA
- Trade Name (English)
- ASSAY FOR THE QUANTITATIVE DETERMINATION OF CREATININE
- Analysis ID
- 0820R2022 SSA
- Registration Date
- August 19, 2022
- Name (Spanish)
- ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTTLABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for CREATININE2 (CREATININE2) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0820R2022 SSA and manufactured by ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on August 19, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.